Cargando…
A novel approach to patients with schizophrenia and type 2 diabetes showing low treatment compliance
INTRODUCTION: Patients with schizophrenia usually demonstrate low compliance to medication. This could be a component of the disorder or a fact that they are not being properly cared. OBJECTIVES: To prevent this in, we tried to treat these patients with long term action antidiabetic agents, in order...
Autores principales: | Argitis, P., Karampas, A., Bringiotti, P., Karavia, S., Pikou, O., Kakavitsas, F.-E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568080/ http://dx.doi.org/10.1192/j.eurpsy.2022.1983 |
Ejemplares similares
-
Antipsychotics induced constipation in patients with mental disorders. treatment suggestion with prucalopride in refractory cases. case report and literature review
por: Mpouras, P., et al.
Publicado: (2022) -
Protocol for the safety of brodalumab regarding psychiatric comorbidities in patients with psoriasis
por: Pikou, O., et al.
Publicado: (2022) -
Mrna vaccination under clozapine treatment
por: Argitis, P., et al.
Publicado: (2022) -
Predictors of compliance in adolescents with type 1 diabetes mellitus
por: Pechnikova, L., et al.
Publicado: (2021) -
Adiponectin, resistin, Interleukine-4, TGF-β2 levels before and after clozapine treatment in a group of first episode, treatment resistant schizophrenia patients
por: Petrikis, P., et al.
Publicado: (2023)